ArticleGenes & diseases2023

LRP1B suppresses HCC progression through the NCSTN/PI3K/AKT signaling axis and affects doxorubicin resistance.

Xiangyu Zhai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.